Cas:51865-79-3 D(-)-Amethopterin manufacturer & supplier

Chemical Name:D(-)-Amethopterin

CAS.NO:51865-79-3

Synonyms:DL-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-;DL-Amethopterin;N-(4-{[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino}benzoyl)glutamic acid;N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid;d-methotrexate;N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid;DL-Methotrexate;DL-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-;DL-4-Amino-N10-methylpteroylglutamic acid;TCMDC-123832;Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-;UNII:99ITO15X8S;Einecs 257-482-2;N-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid;D(-)-Amethopterin;Methotrexate Impurity 6

Molecular Formula:C₂₀H₂₂N₈O₅

Molecular Weight:454.439

HS Code:29335995

Physical and Chemical Properties:

Melting point:195ºC

Boiling point:N/A

Density:1.537g/cm3

Index of Refraction:1.738

PSA:210.54000

Exact Mass:454.171326

LogP:-0.24

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1544 6.1/PG 3

Packing Group:

Contact us for information like DL-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methotrexate Impurity 6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid Use and application,N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid technical grade,usp/ep/jp grade.

Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. D(-)-Amethopterin manufacturer The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. D(-)-Amethopterin supplier AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. D(-)-Amethopterin vendor Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. D(-)-Amethopterin factory China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people.